Abstract | Introduction: Methods: Results: In sum, 274 patients were randomized, 139 received an ACT alone, and 135 received an ACT + primaquine. The mean reduction in Hb at day 7 was similar in each group, a difference in the ACT + PQ versus the ACT alone group of -0.04 g/dL (95% confidence interval [CI] -0.23, 0.31), but the effect of primaquine differed according to G6PD status. In G6PD-deficient patients the drop in Hb was 0.63 g/dL (95% CI 0.03, 1.24) greater in those who received primaquine than in those who received an ACT alone. In G6PD-normal patients, the reduction in Hb was 0.22 g/dL (95% CI -0.08, 0.52) less in those who received primaquine (interaction P = .01). One G6PD normal patient who received primaquine developed moderately severe anaemia (Hb < 8 g/dL). Dark urine was more frequent in patients who received primaquine. Primaquine was associated with a 73% (95% CI 24-90) reduction in gametocyte carriage (P = .013). Conclusion:
Primaquine substantially reduced gametocyte carriage. However, the fall in Hb concentration at day 7 was greater in G6PD-deficient patients who received primaquine than in those who did not and one patient who received primaquine developed moderately severe anemia. Clinical Trial registration: PACTR201411000937373 (www.pactr.org).
|
Authors | Roger C Tine, Khadime Sylla, Babacar T Faye, Eugenie Poirot, Fatou B Fall, Doudou Sow, Duolao Wang, Magatte Ndiaye, Jean Louis Ndiaye, Babacar Faye, Brian Greenwood, Oumar Gaye, Paul Milligan |
Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
(Clin Infect Dis)
Vol. 65
Issue 4
Pg. 535-543
(08 15 2017)
ISSN: 1537-6591 [Electronic] United States |
PMID | 28605472
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. |
Chemical References |
- Antimalarials
- Hemoglobins
- Primaquine
|
Topics |
- Adolescent
- Adult
- Aged
- Antimalarials
(administration & dosage, adverse effects, therapeutic use)
- Female
- Hemoglobins
- Humans
- Malaria, Falciparum
(blood, drug therapy, parasitology, physiopathology)
- Male
- Middle Aged
- Parasitemia
- Plasmodium falciparum
- Primaquine
(administration & dosage, adverse effects, therapeutic use)
- Senegal
- Young Adult
|